Browsing: Homepage Slider
In this editorial, the author discusses the recent advances, trends and future prospects of derivatization techniques for enhancing LC–MS sensitivity.
Novel technology, using single-color digital PCR, could enable the detection of cancerous DNA in circulating blood.
In this interview, we talk to Omnia Ismaiel on her latest article, ‘Do we have mature LC–MS/MS methodology for therapeutic monoclonal antibody bioanalysis?’.
In this Column, Stuart A. Kushon (Neoteryx; CA, USA) discusses what he feels is the key to successful implementation of microsampling.
Bioanalysis of Diagnostic and Therapeutic Oligonucleotides: An Emphasis on LC-FL and LC-MS Based Assays
In this article, recent developments and considerations for liquid chromatographic (LC) methods of oligonucleotides are discussed, highlighting LC-Mass Spectrometry and LC-Fluorescence assays, and the benefits of systematic incorporation into a bioanalysis laboratory.
In this article Johannes Winkler discusses how the recent clinical successes prove that synthetic oligonucleotides are useful therapeutic agents and outlines some obstacles that need to be overcome for a more widespread and safe application.
Bioanalysis Zone and the University of Wisconsin-Madison’s School of Pharmacy are delighted to present a collection of informative webinars on the latest hot topic areas for the bioanalytical community.
Bioanalysis Zone are delighted to partner with The Chromatographic Society at the 22nd International Reid Bioanalytical Forum (4–7 September; Cambourne, UK). We have the pleasure of publishing exclusive content and presentations directly from Reid, including a live stream from the first talk, ‘Bioanalysis of the future’.